ExpertiseUpdated on 23 October 2025
Machine Learning
Computer Engineer at Kedi Mobile Applications
Muğla, Türkiye
About
Seeking a Twinning partnership under the EP PerMed Twinning Call 2026 to advance AI-driven, bioinformatics-based solutions for personalised medicine. The initiative focuses on transferring expertise in multi-omics integration, predictive modelling, and data-driven decision support, accelerating the cross-border implementation of innovative precision-health technologies.
Field
- Screening & early detection programs (risk stratification, predictive tools)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Clinical decision support systems for personalised medicine
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
Organisation
Similar opportunities
Expertise
Citogenetics and Functional Genomics
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Screening & early detection programs (risk stratification, predictive tools)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
Inês Costa
Research Manager at Universidade de Coimbra - Faculdade de Coimbra
Coimbra, Portugal
Expertise
- Clinical decision support systems for personalised medicine
- Screening & early detection programs (risk stratification, predictive tools)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
Arda Temena
Health Informatician at Health Data & Policy Lab
Istanbul, Türkiye
Expertise
Development and phenotyping of genetically engineered mouse models
- Receiver institution with a need to adopt a PM approach
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
Kasım DİRİL
Principal investigator at Izmir Biomedicine and Genome Center
Izmir, Türkiye